The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Fibroblasts as novel therapeutic targets in chronic inflammation
Open accessAbstract
A characteristic feature of many chronic inflammatory diseases is their persistence and predilection for certain sites. The molecular basis for such tissue tropism and failure of the inflammatory response to resolve has until relative recently remained obscure. Recent studies have strongly implicated fibroblasts as cells which contribute to disease persistence and which help define anatomical location. Therefore fibroblasts make an attractive therapeutic target as they help orchestrate the inflammatory infiltrate. Current anti‐inflammatory therapies target immune cells in an attempt to inhibit the production of pro‐inflammatory mediators. However an equally important target is the active induction of pro‐resolution programmes responsible for the resolution of inflammation. Fibroblasts are likely to be an important source of these anti‐inflammatory mediators. Therapeutic manipulation of fibroblasts and their biologically active products is an emerging concept in treating cancer and is likely to provide a novel method to achieve improved control of chronic inflammatory disease. British Journal of Pharmacology (2008) 153, S241–S246; doi:10.1038/sj.bjp.0707487; published online 29 October 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 3×
“, 1996), growth (Dvorak, 1986) and metastasis (Schedin and Elias, 2004).”
BackgroundOrimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation
Buckley, C. D., Pilling, D., Lord, J. M., Akbar, A. N., Scheel-Toellner, D., & Salmon, M. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01863-4 · Cited by 796
Self-citationParrinello, S., Coppe, J.-P., Krtolica, A., & Campisi, J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01635 · Cited by 631 · cited 1×
“Parrinello et al. (2005) found that senescent fibroblasts were able to disrupt the normal branching morphogenesis of breast epithelial cells by secreted factors including MMPs and epithelial growth factors.”
BackgroundYang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215333 · Cited by 404
Two sides of a cellular coin: CD4(+)CD3- cells regulate memory responses and lymph-node organization
Lane, P. J. L., Gaspal, F. M. C., & Kim, M.-Y. (2005) · Nature Reviews Immunology · doi:10.1038/nri1665 · Cited by 76
Cited by
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Cancer associated fibroblasts (CAFs) in tumor microenvironment
Xing, F. (2010) · Frontiers in Bioscience · doi:10.2741/3613 · Cited by 682
Inflammatory mediators in the pathogenesis of periodontitis
Yucel-Lindberg, T., & Båge, T. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.8 · Cited by 472
NF-kappaB Signaling in Chronic Inflammatory Airway Disease
Schuliga, M. (2015) · Biomolecules · doi:10.3390/biom5031266 · Cited by 428
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy
Glenn, J. D. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.526 · Cited by 406
Noss, E. H., & Brenner, M. B. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00648.x · Cited by 357
Kitamura, H., Cambier, S., Somanath, S., Barker, T., Minagawa, S., Markovics, J., Goodsell, A., Publicover, J., Reichardt, L., Jablons, D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45589 · Cited by 189
PU.1 controls fibroblast polarization and tissue fibrosis
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A., Weber, S., Matei, A.-E., Chen, C.-W., Maier, C., et al. (2019) · Nature · doi:10.1038/s41586-019-0896-x · Cited by 187
“In the context of inflammatory and neoplastic diseases 2,3 , fibroblasts can differentiate into a matrix-producing contractile phenotype that promotes progressive accumulation of extracellular matrix and the initiation of fibrotic disease 4–6 In contrast, in chronic inflammatory diseases such as…”
Elastin signaling in wound repair
Almine, J. F., Wise, S. G., & Weiss, A. S. (2012) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.21016 · Cited by 155
Kurgan, S., & Kantarci, A. (2018) · Periodontology 2000 · doi:10.1111/prd.12146 · Cited by 141
“Likewise, their expression of receptors for recognition of proinflammatory and profibrotic stimuli differ from those in lung and skin fibroblasts, resulting in a highly active regulation of tissue turnover by the fibroblast phenotypes in the periodontium (30).”
Rejuvenating the immune system in rheumatoid arthritis.
Weyand, C. M., Fujii, H., Shao, L., & Goronzy, J. J. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.180 · Cited by 112
“The focus of understanding the immune pathology of RA has so far been directed towards macrophages, dendritic cells, T cells and B cells that accumulate in the joints to form highly organized architectures producing autoantibodies, proinflammatory cytokines and bone-destructive mediators”
BackgroundExpression of Prostaglandin E Synthases in Periodontitis
Båge, T., Kats, A., Lopez, B. S., Morgan, G., Nilsson, G., Burt, I., Korotkova, M., Corbett, L., Knox, A. J., Pino, L., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.12.048 · Cited by 63
Zoppi, N., Chiarelli, N., Binetti, S., Ritelli, M., & Colombi, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.005 · Cited by 49
Zoppi, N., Chiarelli, N., Ritelli, M., & Colombi, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040982 · Cited by 37
Metadata
- Authors
- Flavell, S. J., Hou, T. Z., Lax, S., Filer, A. D., Salmon, M., & Buckley, C. D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-03
- Volume
- 153
- Issue
- S1
- Pages
- S241-6
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1751758267
- Cited by
- 186
- References
- 8
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.